Friday, February 4, 2022

Antibiotic ivermectin preferentially targets renal cancer through inducing mitochondrial dysfunction and oxidative damage - PubMed

https://pubmed.ncbi.nlm.nih.gov/28847725/

No comments:

Post a Comment